ALNEV — Neovacs SA Balance Sheet
0.000.00%
Last trade - 00:00
- €0.00m
- -€4.69m
- €0.00m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | FAS | — | FAS | — | FAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.42 | 1.3 | 10.1 | 33.1 | 6.76 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.72 | 5.74 | 2.83 | 1.6 | 1.81 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6.43 | 7.22 | 13.1 | 34.8 | 9.07 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.156 | 0.103 | 0.255 | 0.506 | 0.511 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 7.24 | 7.63 | 13.5 | 48.6 | 55.3 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.73 | 4.73 | 2.42 | 4.65 | 5.12 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4.8 | 4.8 | 2.51 | 4.65 | 5.13 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.44 | 2.83 | 11 | 43.9 | 50.2 |
Total Liabilities & Shareholders' Equity | 7.24 | 7.63 | 13.5 | 48.6 | 55.3 |
Total Common Shares Outstanding |